The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. - Strickland LN; Faraoni EY; Ruan W; Yuan X; Eltzschig HK; Bailey-Lundberg JM (Frontiers in immunology, 2023)